Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"6,876 (4,772, 9,066)","35.3% (25.3%, 45.2%)","73.5% (55.2%, 88.5%)","18.3% (11.9%, 29.4%)","94.3% (90.9%, 96.1%)","12.3 (8.9, 15.8)","25.7 (19.3, 31.0)","6.4 (4.2, 10.3)","33.0 (31.8, 33.6)",,,,,
"p=(None, None), q=(None, None), c=0.500, f=1.00)","7,149 (4,950, 9,412)","43.2% (28.3%, 56.7%)","68.1% (48.6%, 84.7%)","16.1% (10.4%, 26.5%)","95.0% (91.6%, 96.9%)","15.1 (9.9, 19.8)","23.9 (17.0, 29.6)","5.6 (3.6, 9.3)","33.2 (32.0, 33.9)","4.0% (0.7%, 8.7%)","22.6% (7.0%, 48.9%)","-7.5% (-14.0%, -3.5%)","-11.9% (-22.0%, -4.4%)","0.8% (-2.6%, 4.2%)"
"p=(None, None), q=(None, None), c=0.750, f=1.00)","7,304 (5,046, 9,629)","43.8% (28.3%, 56.8%)","66.7% (46.2%, 83.8%)","15.5% (9.8%, 25.6%)","95.1% (92.1%, 97.0%)","15.3 (9.9, 19.9)","23.3 (16.2, 29.3)","5.4 (3.4, 8.9)","33.3 (32.3, 34.0)","6.3% (1.9%, 12.8%)","24.3% (6.9%, 49.4%)","-9.6% (-17.7%, -4.3%)","-15.7% (-26.2%, -8.1%)","0.9% (-2.2%, 4.6%)"
"p=(None, None), q=(None, None), c=1.000, f=1.00)","7,481 (5,160, 9,883)","44.2% (28.3%, 58.9%)","65.4% (44.2%, 83.2%)","14.8% (9.0%, 24.8%)","95.0% (91.2%, 97.0%)","15.5 (9.9, 20.6)","22.9 (15.5, 29.1)","5.2 (3.2, 8.7)","33.3 (31.9, 33.9)","9.0% (2.9%, 18.9%)","25.5% (7.2%, 50.6%)","-11.5% (-21.5%, -5.1%)","-19.3% (-32.0%, -9.8%)","0.8% (-2.4%, 4.4%)"
